Pharmacological inhibition of H4R in vivo has been shown to reduce visceral hypersensitivity and decrease mast cell infiltration in the colon of germ-free mice colonized with fecal microbiome from individuals with high histamine-producing IBS [8]. This evidence concerns the gene HRH4 and irritable bowel syndrome.